Result of EGM
25 6월 2010 - 5:58PM
UK Regulatory
TIDMCMSH
RNS Number : 2451O
China Medical System Holdings Ltd
25 June 2010
+------------------------------------+------------------------------------+
| For Immediate release | 25 June 2010 |
+------------------------------------+------------------------------------+
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR
JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF
THE RELEVANT LAWS OR REGULATION.
China Medical System Holdings Ltd
("CMS" or "the Company")
Results of Extraordinary General Meeting
Results of Extraordinary General Meeting:
China Medical System Holdings Limited (AIM: CMSH) is pleased to announce that at
the Company's Extraordinary General Meeting (the "EGM") held earlier today all
the ordinary resolutions proposed were duly passed. A total of 38,807,294 votes
(representing 81.4% of the issued share capital of the Company) were cast, of
which all the votes were cast in favour of the resolutions.
Issue of Equity:
Following the passing of the resolution to sub-divide each existing authorised
issued and unissued share of a par value of US$0.10 each in the capital of the
Company into 20 new shares of a par value of US$0.005 each (the "Sub-division"),
the Sub-division will become effective at 8:00 a.m. on 28 June 2010. All
references in this announcement are to London time unless otherwise stated. The
reason for the Sub-division is to encourage greater liquidity in the Company's
shares.
An application has been made for admission of new shares to trading on AIM. It
is expected that the last day of dealings in the existing shares will be 25 June
2010 and the effective time for dealings to commence in the new shares will be
8:00 a.m. on 28 June 2010. The existing ISIN of the shares is KYG211081081.
Following the Sub-division, the new ISIN of the shares will be KYG211081164.
Following the Sub-division, the authorised and issued share capital of the
Company will comprise 20,000,000,000 shares and 953,691,440 shares,
respectively, of a par value of US$0.005 each.
Appointment of Independent Non-executive Director ("INED")
At the EGM, an ordinary resolution was passed to appoint Mr. Wu Chi Keung ("Mr.
Wu") as an INED of the Company, such appointment became effective at the
conclusion of the EGM. Upon his appointment as an INED of the Company, Mr. Wu
was also appointed as the Chairman of the Audit Committee of the Company, and a
committee member of each of the Remuneration Committee and the Nomination
Committee of the Company.
Mr. Wu, aged 53, has more than 29 years of experience in financial audit and
specialises in providing auditing and assurance services, financial due
diligence reviews, support services for merger and acquisitions, corporate
restructuring and fund raising engagements. Mr. Wu's prior finance experience
includes mainly working with international accounting firms until 2008 when he
was a partner with Deloitte Touche Tohmatsu. Mr. Wu is currently the managing
director of a family-owned private company (Born Best Company Limited) in Hong
Kong engaging in property and other investment activities. Mr. Wu is an
associate of the Hong Kong Institute of Certified Public Accountants and a
fellow member of the Chartered Association of Certified Accountants in the
United Kingdom. Mr. Wu graduated from Hong Kong Polytechnic University in
November 1980 with a higher diploma in accountancy.
Disclosure under AIM regulations:
Current directorship:
Born Best Company Limited
Previous directorship / partnership in past 5 years:
Deloitte Touche Tohmatsu
At the date of his appointment as a Director, Mr. Wu did not own any ordinary
shares, or options over shares in the capital of the Company.
Save as disclosed above, there is no further information in respect of Mr. Wu's
appointment required to be disclosed pursuant to paragraph (g) of Schedule 2 to
the AIM Rules for Companies.
For further information, please contact:
+---------------------------------------+--------------------+
| China Medical System Holdings Ltd | + (852) 2369 3889 |
+---------------------------------------+--------------------+
| Vincent Hui | |
+---------------------------------------+--------------------+
| Seymour Pierce Limited | + 44 (0)20 |
| | 7107 8344 |
+---------------------------------------+--------------------+
| Chris Howard / Catherine Leftley | |
+---------------------------------------+--------------------+
The information contained in this document is not for release, publication or
distribution, directly or indirectly, in whole or in part, in, into or from in
the United States of America (including its territories and possessions, any
state of the United States and the District of Columbia). These materials do not
contain, constitute or form part of an offer to sell or the solicitation of an
offer to purchase securities in the United States. The securities referred to
herein (the "Securities") have not been and will not be registered under the US
Securities Act of 1933, as amended (the "Securities Act"), and may not be
offered or sold in the United States absent registration under the Securities
Act except pursuant to an available exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act. There will be
no public offer of the Securities in the United States.
Notes for editors
China Medical System Holdings Limited
China Medical System Holdings Ltd., (CMS) is listed on the Alternative
Investment Market (AIM) of the London Stock Exchange with the ticker symbol
"CMSH". It is a marketing and promotional service provider in China for
prescription pharmaceutical products. For further information, please visit
www.chinamedicalsystem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
REGUVVWRRRANURR
China Medical (LSE:CMSH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
China Medical (LSE:CMSH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
